Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Sheehan
D V
DV
University of South Florida, Institute for Research in Psychiatry, Tampa, USA.
Raj
A B
AB
Harnett-Sheehan
K
K
Dorotheo
J
J
Sheehan
M F
MF
Trehan
R
R
Knapp
E
E
Swiontek
A
A
Coleman
B
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D000379:Agoraphobia / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D000525:Alprazolam / Q000008:administration & dosage* / Q000009:adverse effects; D014151:Anti-Anxiety Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016584:Panic Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D003692:Delayed-Action Preparations; D000525:Alprazolam